Prostate cancer histologic trends in the metropolitan Detroit area, 1982 to 1996 - interobserver reproducibility of five different grading systems

By Schwartz K.L.   Grignon D.J.   Sakr W.A.   Wood D.P.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 769-774

Elsevier

Access to resources Recommend Favorite

Cryosurgery for prostate cancer: improved glandular ablation by use of 6 to 8 cryoprobes

By Lee F.   Bahn D.K.   Badalament R.A.   Kumar A.B.   Klionsky D.   Onik G.M.   Chinn D.O.   Greene C.  

Urology, Vol. 54, Iss. 1, 1999-07 ,pp. : 135-140

Elsevier

Access to resources Recommend Favorite

Free/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3–10 ng/ml

By Elabbady Ahmed   Khedr Mahrousa  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 553-557

Springer Publishing Company

Access to resources Recommend Favorite

Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy

By Merrick G.S.   Butler W.M.   Galbreath R.W.   Lief J.H.   Adamovich E.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 98-103

Elsevier

Access to resources Recommend Favorite

Probability of biochemical recurrence by analysis of pathologic stage, gleason score, and margin status for localized prostate cancer

By Khan M.A.   Partin A.W.   Mangold L.A.   Epstein J.I.   Walsh P.C.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 866-871

Elsevier

Access to resources Recommend Favorite